Tscan Therapeutics
$0.3915
25
+$0.02+5.55% Friday 20:00
-$0.00-0.03%Friday 23:50After hours
Statistics
Day High
0.3971
Day Low
0.3939
52W High
2.57
52W Low
0.351
Volume
13,423
Avg. Volume
-
Mkt Cap
26.54M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
11NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.33
-0.29
-0.25
-0.2
Expected EPS
-0.27968
Actual EPS
N/A
Financials
-1,256.81%Profit Margin
Unprofitable10.33MRevenue
-129.77MNet Income
Analyst Ratings
4.67Average Price Target
The highest estimate is 7.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 67%
Hold 33%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TCRX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Gilead Sciences
GILD
Mkt Cap180.64B
Novartis
NVS
Mkt Cap292.35B
Allogene Therapeutics
ALLO
Mkt Cap697.89M
Precigen
PGEN
Mkt Cap2.49B
CRISPR Therapeutics
CRSP
Mkt Cap5.58B
About
TScan Therapeutics Inc is a fully integrated clinical-stage biotechnology company focused on developing a robust pipeline of T cell receptor (TCR)-engineered T cell, or TCR-T, therapies for the treatment of patients with cancer. The company's liquid tumor TCR-T therapy candidates, TSC-100 and TSC-101, are in development for the treatment of patients with hematologic malignancies to eliminate residual leukemia and prevent relapse after hematopoietic stem cell transplantation. It is also developing multiplexed TCR-T therapy candidates for the treatment of various solid tumors.
Show more...
CEO
Gavin MacBeath
Employees
142
Country
United States
ISIN
US89854M1018
Listings
0 Comments
Share your thoughts
FAQ
What is Tscan Therapeutics stock price today?▼
The current price of TCRX is $0.39 USD — it has increased by +5.55% in the past 24 hours. Watch Tscan Therapeutics stock price performance more closely on the chart.
What is Tscan Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Tscan Therapeutics stocks are traded under the ticker TCRX.
Is Tscan Therapeutics stock price growing?▼
TCRX stock has fallen by -48.04% compared to the previous week, the month change is a -48.7% fall, over the last year Tscan Therapeutics has showed a -79.5% decrease.
What is Tscan Therapeutics market cap?▼
Today Tscan Therapeutics has the market capitalization of 26.54M
When is the next Tscan Therapeutics earnings date?▼
Tscan Therapeutics is going to release the next earnings report on November 11, 2026.
What were Tscan Therapeutics earnings last quarter?▼
TCRX earnings for the last quarter are -0.23 USD per share, whereas the estimation was -0.25 USD resulting in a +9.23% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tscan Therapeutics revenue for the last year?▼
Tscan Therapeutics revenue for the last year amounts to 10.33M USD.
What is Tscan Therapeutics net income for the last year?▼
TCRX net income for the last year is -129.77M USD.
How many employees does Tscan Therapeutics have?▼
As of September 06, 2026, the company has 142 employees.
In which sector is Tscan Therapeutics located?▼
Tscan Therapeutics operates in the Health & Wellness sector.
When did Tscan Therapeutics complete a stock split?▼
Tscan Therapeutics has not had any recent stock splits.
Where is Tscan Therapeutics headquartered?▼
Tscan Therapeutics is headquartered in WALTHAM, United States.